Logo

Precipio, Inc.

PRPO

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and… read more

Healthcare

Diagnostics & Research

6 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$20.50

Price

+15.23%

$2.71

Market Cap

$30.697m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$20.570m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$1.801m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.21

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$12.288m

$18.816m

Assets

$6.528m

Liabilities

$2.611m

Debt
Debt to Assets

13.9%

-5.1x

Debt to EBITDA
Free Cash Flow

$565k

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases